Cargando…

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

BACKGROUND: Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with heterogeneous clinical outcomes. Several molecular classifications have been proposed, but the diversity of their subtype sets impedes their clinical application. OBJECTIVE: To achieve an international consensus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamoun, Aurélie, de Reyniès, Aurélien, Allory, Yves, Sjödahl, Gottfrid, Robertson, A. Gordon, Seiler, Roland, Hoadley, Katherine A., Groeneveld, Clarice S., Al-Ahmadie, Hikmat, Choi, Woonyoung, Castro, Mauro A.A., Fontugne, Jacqueline, Eriksson, Pontus, Mo, Qianxing, Kardos, Jordan, Zlotta, Alexandre, Hartmann, Arndt, Dinney, Colin P., Bellmunt, Joaquim, Powles, Thomas, Malats, Núria, Chan, Keith S., Kim, William Y., McConkey, David J., Black, Peter C., Dyrskjøt, Lars, Höglund, Mattias, Lerner, Seth P., Real, Francisco X., Radvanyi, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690647/ https://www.ncbi.nlm.nih.gov/pubmed/31563503 http://dx.doi.org/10.1016/j.eururo.2019.09.006

Ejemplares similares

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification
por: Sjödahl, Gottfrid, et al.
Publicado: (2017)

Intrinsic subtypes and bladder cancer metastasis
por: McConkey, David J., et al.
Publicado: (2016)

Biological determinants of bladder cancer gene expression subtypes
por: Aine, Mattias, et al.
Publicado: (2015)

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
por: Eriksson, Pontus, et al.
Publicado: (2017)

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
por: Cheng, Tiewei, et al.
Publicado: (2013)

Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p
por: Eriksson, Pontus, et al.
Publicado: (2013)

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
por: Eriksson, Pontus, et al.
Publicado: (2015)

Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
por: Sjödahl, Gottfrid, et al.
Publicado: (2022)

Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review
por: Medle, Benjamin, et al.
Publicado: (2022)

Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting
por: Lerner, Seth P., et al.
Publicado: (2016)

Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma
por: Aine, Mattias, et al.
Publicado: (2015)

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
por: Marzouka, Nour-al-dain, et al.
Publicado: (2018)

Molecular subtype classification of urothelial carcinoma in Lynch syndrome
por: Therkildsen, Christina, et al.
Publicado: (2018)

Molecular pathology of the luminal class of urothelial tumors
por: Bernardo, Carina, et al.
Publicado: (2019)

A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
por: Eriksson, Pontus, et al.
Publicado: (2021)

Inhibition of Inducible Heat Shock Protein-70 (Hsp72) Enhances Bortezomib-Induced Cell Death in Human Bladder Cancer Cells
por: Qi, Wei, et al.
Publicado: (2013)

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016)

Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship
por: Marzouka, Nour-Al-Dain, et al.
Publicado: (2020)

Autophagy is required for crizotinib-induced apoptosis in MET-amplified gastric cancer cells
por: Schroeder, Rebecca D., et al.
Publicado: (2017)

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
por: Lang, Hervé, et al.
Publicado: (2022)

Update on bladder cancer molecular subtypes
por: Fong, Megan Hoi Yan, et al.
Publicado: (2020)

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
por: Sjödahl, Gottfrid, et al.
Publicado: (2019)

Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis
por: Roth, Beat, et al.
Publicado: (2016)

p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers
por: Choi, Woonyoung, et al.
Publicado: (2012)

Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation
por: Plote, Devin, et al.
Publicado: (2019)

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
por: Baker, Simon C., et al.
Publicado: (2022)

Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015)

A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
por: Sjödahl, Gottfrid, et al.
Publicado: (2011)

An essential role for decorin in bladder cancer invasiveness
por: El Behi, Mohamed, et al.
Publicado: (2013)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays
por: Jakobsson, Lovisa, et al.
Publicado: (2018)

Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
por: Lindgren, David, et al.
Publicado: (2012)

FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
por: Foth, Mona, et al.
Publicado: (2018)

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection
por: Eriksson, Pontus, et al.
Publicado: (2023)

Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
por: Neyret-Kahn, Hélène, et al.
Publicado: (2023)

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
por: Pfister, Christian, et al.
Publicado: (2020)

A Brief Measure of Parental Wellbeing for Use in Evaluations of Family-Centred Interventions for Children with Developmental Disabilities
por: McConkey, Roy
Publicado: (2020)

Responding to Autism in Low and Middle Income Countries (Lmic): What to Do and What Not to Do
por: McConkey, Roy
Publicado: (2022)

ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma
por: Kim, Michael P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_odnksdve0750opd5at0d2j5cgr